Qube Research & Technologies (QRT)
UBX

Qube Research & Technologies (QRT)’s Unity Biotechnology UBX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18
Closed -$25 – 4138
2024
Q2 		$25 Hold
18
– – ﹤0.01% 3560
2024
Q1 		$30 Hold
18
– – ﹤0.01% 4244
2023
Q4 		$35 Hold
18
– – ﹤0.01% 4100
2023
Q3 		$43 Buy
+18
New +$48 ﹤0.01% 3829
2021
Q3 		– Sell
-4,513
Closed -$209K – 2794
2021
Q2 		$209K Buy
+4,513
New +$217K ﹤0.01% 1780

Other funds holding UBX

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

Qube Research & Technologies (QRT)'s UBX Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Unity Biotechnology (UBX) in Q3 2024, closing a stake of 18 shares — an estimated $25 sold.

Qube Research & Technologies (QRT) first reported a position in UBX in Q2 2021 and held it in 5 quarters. The position peaked at $209K in Q2 2021. 38 funds tracked by Wall St. Rank hold UBX as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Unity Biotechnology position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 18 Unity Biotechnology shares in Q3 2024, an estimated $25.
  • Qube Research & Technologies (QRT) first reported a position in Unity Biotechnology in Q2 2021 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Unity Biotechnology position peaked at $209K in Q2 2021.
  • 38 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.